Trials / Withdrawn
WithdrawnNCT01051128
Continuous Intrathecal Baclofen Infusion for Chronic Spasticity
Continuous Intrathecal Baclofen Infusion for the Management of Chronic Spasticity
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Flowonix Medical · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical investigation is to demonstrate product performance of the Prometra Programmable Pump System in the delivery of intrathecal Lioresal® (baclofen) for the management of severe spasticity.
Detailed description
The Prometra Programmable Pump is a battery-operated, implantable, programmable infusion pump that dispenses drug solution into the intrathecal space through an implanted infusion catheter. All functions of the system (e.g., dosing) are controlled externally using a hand-held, battery-operated programmer. Lioresal Intrathecal (baclofen) is indicated for use in the management of severe spasticity. Spasticity is a major problem that has long challenged traditional medical treatment. While the incidence of spasticity is not known with certainty, it likely affects over half a million people in the United States and over 12 million worldwide. Spasticity is associated with some very common neurological disorders such as: multiple sclerosis, stroke, cerebral palsy, spinal cord and brain injuries. Chronic spasticity seriously restricts normal daily activities and reduces the quality of life for many patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Prometra Programmable Implantable Pump System | The Prometra Programmable Pump is a battery-operated, implantable, programmable infusion pump that dispenses drug solution into the intrathecal space through an implanted infusion catheter. All functions of the system (e.g., dosing) are controlled externally using a hand-held, battery-operated programmer. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Completion
- 2010-12-01
- First posted
- 2010-01-18
- Last updated
- 2015-03-06
Source: ClinicalTrials.gov record NCT01051128. Inclusion in this directory is not an endorsement.